SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak(R) platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced the appointment of Rick Bright, Ph.D., Philip Krause, M.D., Mario Barro, […]
TAMPA, Fla. and WAYNE, N.J., Sept. 19, 2024 (GLOBE NEWSWIRE) — NewVue, a leader in cloud-native radiology workflow solutions, and Konica Minolta Healthcare Americas, Inc., a leading provider of medical diagnostic imaging and healthcare information technology, announce a strategic partner agreement. This partnership allows Konica Minolta to offer NewVue’s innovative EmpowerSuite Radiology Workflow Orchestrator and
PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating The Scotts Miracle-Gro Company (NYSE: SMG) (“Scotts”) on behalf of the company’s long-term investors. https://kaskelalaw.com/case/scotts-miracle-gro/ Recently a securities fraud complaint was filed against Scotts on behalf of investors who purchased shares of the company’s stock between November 3, 2021 and
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) — LifeMD, Inc.(R) (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced significant enhancements to its weight management program, underscoring the company’s commitment to expanding patient access and improving the quality and comprehensiveness of care available on its virtual care platform. The investments include a
Cincinnati, OH, Sept. 19, 2024 (GLOBE NEWSWIRE) — Claritas, a leader in data-driven marketing solutions, has released its highly anticipated 2024 Hispanic Market Report, offering an in-depth analysis of the burgeoning U.S. Hispanic market. The report underlines that Hispanics now represent over 20% of the U.S. population, with projections showing continuous growth over the next
PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Fate Therapeutics, Inc. (NASDAQ: FATE) (“Fate”) on behalf of the company’s long-term shareholders. https://kaskelalaw.com/case/fate-therapeutics/ Recently an amended securities fraud complaint was filed against Fate on behalf of investors who purchased shares of the company’s stock between August 5, 2020 and
PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Dentsply Sirona Inc. (NASDAQ: XRAY) (“Dentsply”) on behalf of the company’s long-term shareholders. https://kaskelalaw.com/case/dentsply-sirona/ Recently an amended securities fraud complaint was filed against Dentsply on behalf of investors who purchased shares of the company’s stock between June 9, 2021 and
BERKELEY HEIGHTS, N.J., Sept. 19, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has entered into a new commercial supply contract with a top-tier mid-sized dialysis operator for the supply of DefenCath(R) (taurolidine and heparin) to dialysis clinics
PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Inari Medical, Inc. (NASDAQ: NARI) on behalf of the company’s long-term shareholders. https://kaskelalaw.com/cases/inari-medical/ Recently a securities fraud complaint was filed against Inari Medical on behalf of investors who purchased shares of the company’s stock between February 24, 2022 and February
PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Globe Life Inc. (NYSE: GL), formerly known as Torchmark Corp., on behalf of the company’s long-term shareholders. https://kaskelalaw.com/case/globe-life/ Recently a securities fraud complaint was filed against Globe Life on behalf of investors who purchased shares of the company’s stock between